As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
At Talis Biomedical, a filing with the SEC revealed that on Wednesday, Director Matthew L.
Posard bought 62,500 shares of TLIS, at a cost of $16.00 each, for a total investment of $1M.
Posard was up about 53.0% on the buy at the high point of today's trading session, with TLIS trading as high as $24.48 in trading on Monday.
Talis Biomedical is trading up about 5.7% on the day Monday.
This buy marks the first one filed by Posard in the past year.
And also on Wednesday, EVP, CFO Matthew Alan Switzer bought $644,000 worth of Southern National Bancorp Of Virginia, buying 50,000 shares at a cost of $12.88 each.
This purchase marks the first one filed by Switzer in the past twelve months.
Southern National Bancorp Of Virginia is trading up about 1.7% on the day Monday.
So far Switzer is in the green, up about 6.1% on their purchase based on today's trading high of $13.67.